NanoSyrinx
Founded 2020 · $22.1M raised
- Founded
- 2020
- Website
- nanosyrinx.com
- Total Funding
- $22.1M
- Last Round
- $13.6M Venture RoundSep 2024
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
NanoSyrinx is a discovery-stage synthetic-biology company developing a targeted intracellular delivery platform for therapeutic proteins and peptides. Its Nanosyringe system is designed to deliver these molecules directly to the cytosol, addressing the difficulty of reaching the interior of cells. The company was created to commercialize technology discovered by the Waterfield Group at the University of Warwick Medical School.
Summary
NanoSyrinx is a Biotech company, founded in 2020. It has raised $22.1M in total across 2 rounds, most recently a $13.6M Venture Round in Sep 2024. Investors include Octopus Ventures, M Ventures and BGF.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2024
Sign up to see all 2 events
Funding: Seed through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nanosyrinx"><img src="https://indexed.vc/api/badge/company/nanosyrinx" alt="NanoSyrinx on Indexed.vc" width="260" height="76" /></a>